Top Story

Higher CV risk with acarbose than metformin in type 2 diabetes

March 27, 2015
In patients with type 2 diabetes, an initial regimen of acarbose therapy was associated with a moderately higher risk for cardiovascular disease compared with metformin therapy, according to recent findings.

In the nationwide cohort study, Lee-Ming Chuang, MD, PhD, of Nationwide Taiwan University Hospital, and colleagues evaluated data from the Taiwan National Health Insurance Database. The database includes information on outpatient visits, hospital admissions, prescriptions, disease and deaths for 99% of the population of Taiwan.

In the Journals

Updated diabetes care guidelines for PCPs stress importance of individualized treatment

March 23, 2015
Recent updates to the American Diabetes Association’s Standards of Medical Care in Diabetes place an emphasis on individualizing and tailoring care to each…
In the Journals

Diabetes prevalence lower in patients with familial hypercholesterolemia than unaffected relatives

March 11, 2015
Patients with familial hypercholesterolemia had a lower prevalence of type 2 diabetes compared with relatives without familial hypercholesterolemia, according to a…
Gabriela Vazquez-Benitez In the Journals

Diabetes, CVD increase rates of CV events

February 27, 2015
Among adults with diabetes, paying extra attention to traditional cardiovascular risk factors could reduce the rates of cardiovascular events and mortality, according to…
CME
Best of Lipid Forum III

Best of Lipid Forum III

This activity is supported by an educational grant from Amgen, Inc.

Appropriate therapies for various dyslipidemias remain a challenge for practitioners struggling to reduce residual risk…
More »
Meeting News Coverage Video
thumbnail for video 3857626096001

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
In the Journals

HF severity correlated with diabetes risk

May 21, 2014
Increasing severity of HF was associated with greater risk for the development of diabetes in a new study.However, researchers found that use of…
Meeting News CoverageVideo

Video: Specialized care recommendations for Hispanic patients with diabetes

May 21, 2014
Larissa Aviles-Santa, MPH, FACP, FACE, medical officer with the NHLBI’s Division of Cardiovascular Sciences, encourages physicians working…
Meeting News Coverage

Look AHEAD: Despite ‘negative’ findings, trial offers insight and benefits

May 15, 2014
LAS VEGAS – Despite findings of futility in its primary endpoint of cardiovascular improvement, experts here said the Look AHEAD trial gave…
Meeting News Coverage

Goals for lipids, blood pressure levels needed in prediabetes

May 14, 2014
LAS VEGAS — While the American Association of Clinical Endocrinologists guidelines for diabetes prevention offer an HbA1c goal of normoglycemia…
In the Journals

Intensive insulin improved MI survival for patients with diabetes

May 13, 2014
Intensive insulin treatment was associated with an extra 2.3 years of survival after MI in patients with diabetes, according to new findings from the…
In the JournalsPerspective

Yoga may improve CVD risk factors

May 2, 2014
A new meta-analysis suggests that regular yoga practice may have clinically important effects on risk factors for CVD. According to previous…
In the Journals

Nocturnal hypoglycemia may increase arrhythmia risk in type 2 diabetes

May 2, 2014
Nocturnal hypoglycemia may be linked to bradycardia, atrial ectopic activity and other cardiac arrhythmia in patients with type 2 diabetes, according…
In the JournalsPerspective

Diabetes, vascular disease connection differs by phenotype

April 30, 2014
Clear links exist between diabetes and vascular disease but differ depending on vascular phenotype, according to findings published in Diabetes
In the Journals

Email, text, video show potential to improve chronic disease care

April 23, 2014
In a new study, many patients with chronic diseases that included hypertension, diabetes and vascular disease expressed an interest in using…
In the Journals

Email, text, video show potential to improve chronic disease care

Cardiology Today, June 2014
In a new study, many patients with chronic diseases that included hypertension, diabetes and vascular disease expressed an interest in using…
More Headlines »
morganatic-roan